BA Tech — SHANGHAI BA TECHNOLOGY CO., LTD.
BA Tech · Enabling Global Access to Chinese Innovation

Advancing Global
Biopharma & Biotech
With Chinese Solutions

We help international partners evaluate and deploy China's advanced biopharma, cell & gene therapy (CGT), synthetic biology, and specialized manufacturing capabilities, delivering an end-to-end pathway from bidirectional In/Out-Licensing to automated cGMP production equipment.

Founded by Tsinghua alumni with international experience · Connected across EAEU, Europe, Japan & Korea, and the Middle East

Capabilities & Regional Overview
Core Focus

Biologics & Synthetic Biology · CGT Automation · Industrial Equipment

Compliance Standard

Aligned with International cGMP & Target Regulatory Pathways

Key Regions

Eurasia (EAEU) · Europe · Japan & Korea · Middle East

Through an asset-light, execution-focused partnership model, we bridge innovative developers and overseas partners from technology licensing to commercial-scale deployment.
5+Years

Sustained track record in overseas project & supply chain delivery

24+Years

Core team experience in international biopharma & BD execution

~$30MUSD

Cumulative cross-border licensing and equipment delivery value

About Us

Your Long-Term Industrial Partner Connecting Chinese Innovation to Global Markets

Shanghai BA Technology Co., Ltd. (BA Tech) is a China-based, globally oriented industrial collaboration and business development partner in biopharmaceuticals and synthetic biology.

BA Tech connects technology, products, industrial resources, and commercial opportunities between China and international markets, delivering integrated solutions spanning R&D collaboration, product sourcing, resource integration, international BD, and on-the-ground execution.

Grounded in rigorous technical evaluation and disciplined operational coordination, we help global partners bridge the gap from proof-of-concept to commercial-scale implementation for sustainable long-term value.

Core Advantages | Why BA Tech

01

Cross-Cultural BD & Multi-Jurisdiction Alignment

Fluent in Chinese, English, Japanese, and Russian business workflows, we collaborate with qualified local regulatory specialists to support registration and compliance across target markets while mitigating cross-border execution risk.

02

Technical Depth & End-to-End Integration

Our core team combines Tsinghua academic roots with seasoned international industry leadership across biologics, automated bioprocessing, and cGMP compliance, guiding technical evaluation, partner matching, deal structuring, and execution.

03

Execution Beyond Deal Signing

We go beyond licensing introductions and one-off procurement, coordinating critical equipment integration alongside steady-state reagent and consumable supply to sustain long-term commercial value.

Capabilities

Three Interconnected Business Pillars

Building an end-to-end international execution framework, from frontier asset licensing to automated equipment delivery and resilient supply chain coordination.

01

Cross-Border Biopharma & Synthetic Biology Licensing

Targeted sourcing, asset evaluation, and bidirectional In/Out-Licensing of clinical biopharma pipelines and synthetic biology technologies.

Key Scopes & Deliverables
•Technical evaluation and cross-border licensing of clinical-stage AAV, CAR-T, and related CGT assets
•In/Out-Licensing for high-yield strain engineering and enzymatic biomanufacturing technologies
•Cross-regional regulatory alignment, clinical mutual-recognition pathways, and BD execution
•Cross-jurisdiction transaction structuring and intellectual property compliance support
02

CGT Process Automation & Equipment Delivery

Collaborating with specialized domestic engineering partners to deliver cGMP-compliant, automated production systems ready for process validation.

Key Scopes & Deliverables
•All-in-One automated cell therapy manufacturing systems and modular processing platforms
•Microfluidic cell encapsulation and 3D microsphere/microcarrier process development
•Closed, automated 3D cell expansion and perfusion culture system integration
•Automated low-shear cell harvesting, washing, and closed aseptic transfer units
•cGMP-compliant aseptic filling and final formulation workstations
03

Industrial Equipment Supply & Local Deployment

Leveraging China's advanced bioprocess equipment network for equipment selection, commissioning, training, and ongoing service.

Key Scopes & Deliverables
•High-precision sterile tube welders and RF heat sealers for blood centers and biomanufacturing
•Closed aseptic fluid transfer, single-use flow paths, and automated aseptic connection systems
•1,000L pilot-scale industrial bioreactor scale-up engineering and full SOP validation
•Supplier cGMP audits, FAT/SAT acceptance, localized SOP handover, and steady-state consumable supply
Track Record

Selected Projects & Cross-Border Execution

Cross-border collaborations spanning innovative drug licensing, automated cell therapy processes and equipment delivery, sterile medical supply chains, and synthetic biology scale-up across Eurasia, Europe, and Asia-Pacific.

Eurasia · EAEUBiopharma Out-Licensing

Cross-Border Licensing & Market Access for a Phase III AAV Gene Therapy

Novel Gene Therapy · Multi-Center Clinical Trials

Facilitated the cross-border out-licensing of a proprietary Phase III AAV gene therapy developed in China. Coordinated the licensee's Phase III bridging clinical trials in target EAEU jurisdictions, alongside clinical supply and post-approval commercial drug supply.

TurkeyBlood Bank & Plasma Center Equipment

Sterile Tube Welding Systems & Consumables for Blood and Plasma Centers

Sterile Tube Welding · Matched Consumables · Steady Supply

Supplied integrated high-precision sterile tube welders and matched single-use consumables to national and commercial blood centers, apheresis centers, and hospitals, supported by ongoing technical maintenance and local service to safeguard closed-system sterility.

JapanCGT Equipment & Supply Chain

Sterile Tube Welders & Automated CAR-T Equipment for Japanese Pharma and CDMOs

Tube Welders · All-in-One & Modular CAR-T Systems · Pharma & CDMOs

Met strict aseptic closed-system and compliance standards for leading Japanese pharmaceutical manufacturers and CDMOs, delivering validated precision sterile tube welders, All-in-One CAR-T systems, modular processing equipment, and matched sterile consumables for commercial operations.

Cross-RegionalSynthetic Biology Scale-Up & Licensing

Technology Licensing & Commercial Scale-Up for Single-Cell Protein (SCP)

Biomanufacturing IP Licensing · 1,000L Pilot-to-Commercial Scale-Up · Line Engineering

Advanced cross-border IP licensing and industrial collaboration for a synthetic biology single-cell protein (SCP) biomanufacturing platform, supporting process engineering, core equipment selection, and commercial line development from 1,000L pilot validation to commercial scale.

SwitzerlandAutomated Process & Equipment Development

Automated Manufacturing Process & Modular Platform for a Clinical-Stage Cell Therapy

Regenerative Medicine · Automated Cell Processing · Modular Platform

Supported a Swiss biotech company's transition from manual handling to closed, automated cell therapy manufacturing, co-developing modular process units covering cell encapsulation, dynamic culture, automated harvesting, and aseptic filling to enable progression toward commercial-scale cGMP manufacturing.

Ecosystem

Integrating China's Biopharma R&D and Advanced Manufacturing Network

Connecting China's universities, research institutes, and biopharma and life science supply network to align with overseas partners' R&D, product sourcing, and manufacturing requirements, driving cross-border technology collaboration and commercialization.

01

Biopharma & Synthetic Biology Innovation

Focusing on differentiated antibody and cell & gene therapy (CGT) pipelines alongside frontier synthetic biology and biomanufacturing technologies, connecting vetted R&D assets to advance technology sourcing, international licensing, and cross-border collaboration.

02

Biopharma & Life Science Supply Chain

Integrating bioprocessing equipment, laboratory instrumentation, in vitro diagnostics (IVD), and critical reagents and consumables across R&D, process development, and manufacturing, providing overseas partners with cost-effective, dependable supply and technical support.

03

Academic & Translational Research Network

Leveraging our core team's deep academic ties, we connect China's leading universities, research institutes, and state key laboratories in biopharmaceuticals and bioengineering with global partners to drive translational research, technology transfer, joint R&D, and commercialization.

Business Inquiries

Start a Cross-Border
Biopharma & Biotech Collaboration

Whether you are exploring cross-border pipeline licensing, custom automated bioprocess equipment, or supply chain integration in China, we welcome your inquiry. A managing partner for the relevant practice will respond within 3 business days.

Business Emailcontact@shbatech.com
LocationShanghai, China
Send Business Email